Detail akcie Health Sciences online

Business Summary: Health Sciences Group, Inc. identifies, develops and commercializes products and functional food ingredients derived from natural sources to provide consumers and healthcare professionals with preventive healthcare alternatives. The Company has two operating subsidiaries: BioSelect Innovations, Inc. and Swiss Research, Inc. BioSelect Innovations has developed a number of product formulations. These patents address the integration of selective traditional over-the-counter generic drugs with complementary alternative medications, such as vitamins, herbs and other natural nutraceutical supplements. Swiss Research is a diet and nutrition products company, which markets and sells Shugr, a zero-calorie and diabetic safe sugar substitute with the look, taste and baking qualities of cane sugar. The Company will launch its new product, Sequesterol Advance Cardio Formula in April 2006.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2012, Health Sciences Group, Inc. revenues increased 82% to $358K. Net loss decreased 18% to $54K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other selling, general and administrativ decrease of 43% to $31K (expense), Depreciation and amortization decrease of 10% to $10K (expense).